| Literature DB >> 26196264 |
Damon J A Toth, Adi V Gundlapalli, Karim Khader, Warren B P Pettey, Michael A Rubin, Frederick R Adler, Matthew H Samore.
Abstract
While the ongoing Ebola outbreak continues in the West Africa countries of Guinea, Sierra Leone, and Liberia, health officials elsewhere prepare for new introductions of Ebola from infected evacuees or travelers. We analyzed transmission data from patients (i.e., evacuees, international travelers, and those with locally acquired illness) in countries other than the 3 with continuing Ebola epidemics and quantitatively assessed the outbreak risk from new introductions by using different assumptions for transmission control (i.e., immediate and delayed). Results showed that, even in countries that can quickly limit expected number of transmissions per case to <1, the probability that a single introduction will lead to a substantial number of transmissions is not negligible, particularly if transmission variability is high. Identifying incoming infected travelers before symptom onset can decrease worst-case outbreak sizes more than reducing transmissions from patients with locally acquired cases, but performing both actions can have a synergistic effect.Entities:
Keywords: Africa; Ebola; Ebola virus; Guinea; Liberia; Sierra Leone; mathematical model; outbreaks; public health; risk assessment; surveillance; transmission; viruses
Mesh:
Year: 2015 PMID: 26196264 PMCID: PMC4517734 DOI: 10.3201/eid2108.150170
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Characteristics of Ebola case-patients reported outside Guinea, Sierra Leone, and Liberia*
| Case-patients | Year and month | Country | Circumstance of infection | No. transmissions |
|---|---|---|---|---|
| 1 | 2014 Jul | Nigeria | Imported by traveler | 13 |
| 2–4 | 2014 Jul–Aug | Nigeria | Locally acquired | 1 |
| 5–19 | 2014 Jul–Aug | Nigeria | Locally acquired | 0 |
| 20 | 2014/Aug | Nigeria | Locally acquired | 3 |
| 21–23 | 2014/Aug | Spain, United Kingdom, Germany | Evacuated | 0 |
| 24 | 2014/Aug | Senegal | Imported by traveler | 0 |
| 25–27 | 2014/Aug–Sep | United States | Evacuated | 0 |
| 28 | 2014/Sep | France | Evacuated | 0 |
| 29 | 2014/Sep | United States | Imported by traveler | 2 |
| 30 | 2014/Sep | Spain | Evacuated | 1 |
| 31–32 | 2014/Oct | United States | Locally acquired | 0 |
| 33 | 2014/Oct | Spain | Locally acquired | 0 |
| 34–35 | 2014/Oct | Germany | Evacuated | 0 |
| 36 | 2014/Oct | Norway | Evacuated | 0 |
| 37 | 2014/Oct | United States | Imported by traveler | 0 |
| 38 | 2014/Oct | Mali | Imported by traveler | 0 |
| 39–40 | 2014/Oct–Nov | United States | Evacuated | 0 |
| 41 | 2014/Nov | France | Evacuated | 0 |
| 42 | 2014/Nov | Mali | Imported by traveler | 5 |
| 43–44 | 2014/Nov | Mali | Locally acquired | 1 |
| 45–49 | 2014/Nov | Mali | Locally acquired | 0 |
| 50–52 | 2014/Nov | United States, Switzerland, Italy | Evacuated | 0 |
| 53 | 2014/Dec | The Netherlands | Evacuated | 0 |
| 54 | 2014/Dec | United Kingdom | Imported by traveler | 0 |
| 55–56 | 2015/Mar | United Kingdom, United States | Evacuated | 0 |
*These data are published and publicly available as of April 24, 2015. Month/year is when patients were transferred or diagnosed. References by country: Nigeria (,); Spain (,); United Kingdom (,); Senegal ();United States (,,,); Mali (–); other countries ().
Summary of Ebola data and parameter estimates*
| Patient group | No. | Transmissions | ||
|---|---|---|---|---|
| All | 56 | 29 | 0.5 (0.2–1.0) | 0.09 (0.03–0.2) |
| Traveler | 7 | 19 | 2.9 (0.6–6.1) | 0.4 (0.2–1.3) |
| Evacuated patient | 20 | 1 | 0.05 (0–0.1) | ∞ |
| Patient with locally acquired Ebola | 29 | 9 | 0.3 (0.1–0.5) | 0.5 (0.2–∞) |
*Cases were included if the patient spent any of the infectious period in a country other than Guinea, Liberia, or Sierra Leone. The 56 patients are split into 3 mutually exclusive subgroups, depending on the patients’ circumstances. Parameters R and k of the negative binomial distribution are the reproductive number and dispersion parameter, respectively. Goodness of fit was not rejected by a Kolmogorov–Smirnov test (p>0.6 in all cases).
Figure 1Exceedance risk curves for total number of transmissions in an Ebola outbreak following a single-case introduction. Solid lines, k = 1; dashed lines, k = 0.1; dash-dot lines, k = 10. A) R0 = 3 for initial case, assumed to be traveler during incubation or symptomatic period; and Rc = 0.3 for subsequent cases, assumed to be locally acquired cases in countries other than Guinea, Sierra Leone, or Liberia. B) R0 = 3 for initial case, assumed to be patients evacuated for treatment; and Rc = 0.1 for subsequent cases. C) R = 0.3 for all cases. D) R = 0.1 for all cases.
Figure 2Comparison of worst-case Ebola outbreak sizes after a single-case introduction under different scenarios. Comparisons of the outbreak size expected to be exceeded after A) 1% of introductions and B) 0.01% of introduction of a single initial case, under different assumptions for the reproductive number R and dispersion parameter k. In all cases, higher transmission variability (lower k) leads to higher worst-case estimates. From the R0 = 3, Rc = 0.3 case, reducing Rc to 0.1 for cases after the initial case has less effect than reducing the initial case R0 to 0.3. Reducing both the initial and subsequent cases’ R to 0.1 has a synergistic effect.